Profile data is unavailable for this security.
About the company
Baxter International Inc. through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.
- Revenue in USD (TTM)13.55bn
- Net income in USD1.06bn
- LocationBaxter International IncDF2-1W, ONE BAXTER PKWYDEERFIELD 60015United StatesUSA
- Phone+1 (847) 948-2000
- Fax+1 (302) 655-5049
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|BAX:NYQ since |
|Hill-Rom Holdings Inc||Deal completed||02 Sep 2021||02 Sep 2021Deal completed||-15.19%||10.42bn|